How does the price of mitotane compare to other drugs?

Mitotane is a specialized treatment drug for adrenal cortical cancer. Due to its high research and development costs and relatively rare indications, its price in the global market is generally high. At present, the original drug of mitotane has been approved for marketing in many countries, such as European countries and the Turkish market. The common specification is 500mg × 100 tablets per box. Its overseas selling price is about 9,000 yuan, and the specific amount will be adjusted according to exchange rate fluctuations. Although mitotane has been registered as an original product in mainland China, due to its short time on the market, it has not yet been included in the national medical insurance catalog, and mature market pricing has not yet been formed. Most patients need to pay for it out of pocket.

In this context, some patients have begun to seek overseas generic drugs as alternatives. Take the Lao version of mitotane as an example. Its common specifications are the same as the original drug, but the price may be as low as about 2,000 yuan. On the premise of ensuring consistent ingredients, the economic advantage is obvious. However, it should be emphasized that although generic drugs are similar in chemical composition and specifications, they may have differences in production standards, quality control, stability verification, etc. Therefore, when patients purchase generic drugs, they should obtain them through formal channels and communicate with their doctors to confirm their substitutability.

From the overall drug price comparison, the price of mitotane is much higher than that of common anti-cancer drugs. Especially in the absence of medical insurance support, the financial burden cannot be ignored. However, considering its unique role in the treatment of adrenocortical cancer, there is currently a lack of real alternative drugs and it is still one of the preferred clinical treatment options. Therefore, how to reduce medication costs while ensuring efficacy is an important issue currently faced by patients and doctors.

Reference materials:https://go.drugbank.com/drugs/DB00648